Literature DB >> 16944365

[Malignant gliomas--radiotherapy].

Annemarie Schratter-Sehn1.   

Abstract

Postoperative radiotherapy is the treatment of choice for high grade gliomas and glioblastomas. The goal of the adjuvant radiotherapy is to improve local control and long term survival. The benefit of re-irradiation for recurrent or progressive glioma is controversial. The therapeutic benefit of any radiotherapy intervention must be balanced by the risk of neurotoxicity and its impact on quality of life.

Entities:  

Mesh：

Year:  2006        PMID： 16944365     DOI： 10.1007/s10354-006-0306-5

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN： 0043-5341


  31 in total

1.  Neon heavy charged particle radiotherapy of glioblastoma of the brain.

Authors:  J R Castro; T L Phillips; M Prados; P Gutin; D A Larson; P L Petti; I K Daftari; J M Collier; P Lillis-Hearne
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-05-01       Impact factor: 7.038

2.  What is the appropriate radiotherapy protocol for older patients with newly diagnosed glioblastoma?

Authors:  Johannes Lutterbach; Christoph Ostertag
Journal:  J Clin Oncol       Date:  2005-04-20       Impact factor: 44.544

3.  Rapid-course radiation therapy of cerebral metastases: results and complications.

Authors:  D F Young; J B Posner; F Chu; L Nisce
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

4.  Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study.

Authors:  M Klein; J J Heimans; N K Aaronson; H M van der Ploeg; J Grit; M Muller; T J Postma; J J Mooij; R H Boerman; G N Beute; G J Ossenkoppele; G W van Imhoff; A W Dekker; J Jolles; B J Slotman; H Struikmans; M J B Taphoorn
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

5.  Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group.

Authors:  G M Kiebert; D Curran; N K Aaronson; M Bolla; J Menten; E H Rutten; E Nordman; M E Silvestre; M Pierart; A B Karim
Journal:  Eur J Cancer       Date:  1998-11       Impact factor: 9.162

6.  Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

Authors:  W Roa; P M A Brasher; G Bauman; M Anthes; E Bruera; A Chan; B Fisher; D Fulton; S Gulavita; C Hao; S Husain; A Murtha; K Petruk; D Stewart; P Tai; R Urtasun; J G Cairncross; P Forsyth
Journal:  J Clin Oncol       Date:  2004-03-29       Impact factor: 44.544

7.  Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group.

Authors:  D F Nelson; M Diener-West; J Horton; C H Chang; D Schoenfeld; J S Nelson
Journal:  NCI Monogr       Date:  1988

8.  Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme.

Authors:  Nathan S Floyd; Shiao Y Woo; Bin S Teh; Charlotte Prado; Wei-Yuan Mai; Todd Trask; Philip L Gildenberg; Paul Holoye; Mark E Augspurger; L Steven Carpenter; Hsin H Lu; J Kam Chiu; Walter H Grant; E Brian Butler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-03-01       Impact factor: 7.038

9.  Meta-analytic re-evaluation of misonidazole in the treatment of high grade astrocytoma.

Authors:  M Huncharek
Journal:  Anticancer Res       Date:  1998 May-Jun       Impact factor: 2.480

Review 10.  Chemotherapy for high-grade gliomas.

Authors:  E Galanis; J Buckner
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.